Approval · Notice of Compliance 16955 · 2015
ESTRAGYN: Notice of Compliance 16955
Issued June 1, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16955
- Date
- June 1, 2015
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
- Therapeutic class
- Estrogen
Products in this notice
Medicinal ingredients
- ESTERIFIED ESTROGENS 0.625 MG per TAB
- ESTERIFIED ESTROGENS 0.3 MG per TAB